IDH1 and central nervous system cancer: The activity of IDH1 enzyme in protecting CSC from oxidative damage has also been observed in glioma-initiating cells (GIC), where IDH1 inactivation, via silencing or pharmacological inhibition, diminishes NADPH production, reduces GSH levels, and increases ROS, thereby reducing GIC frequency [48].